BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
$9.51 -0.01 (-0.105%)
Analysed BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) News Sources
BioCryst to Report First Quarter 2026 Financial Results on May 6
15-04-2026
yahoo.com
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06-04-2026
yahoo.com
How The BioCryst Pharmaceuticals (BCRX) Narrative Is Shifting With Astria Deal And FY26 Targets
05-04-2026
yahoo.com
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
BioCryst Shares Remain Undervalued, RBC Says
25-03-2026
yahoo.com
BioCryst (BCRX) Rallies 7.10% on Acquisition Buzz
20-03-2026
yahoo.com
BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
19-03-2026
yahoo.com
BioCryst Takeover Rumors Test Investor Focus On Fundamentals And Optionality
19-03-2026
yahoo.com
BioCryst (BCRX) Soars 13% on Acquisition Buzz
17-03-2026
yahoo.com
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush
10-03-2026
yahoo.com
What is the current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is $9.51.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is $-0.01.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is -0.105%.
What is the most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is .
SEC-8K** Filing Available For BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.